All Stories

  1. Molecular structure, reactivity, and anti-breast cancer potential of quinazoline–pyrimidine hybrids against MDA-MB-231 cells: a combined experimental and computational study

    Article • Journal of Molecular Structure, September 2026, Elsevier

    Dr Shankar G Alegaon

  2. New pyrimidine compounds as potent anti-breast cancer agents: synthesis, biological evaluation and computational studies

    Article • Bioorganic Chemistry, August 2026, Elsevier

    Dr Shankar G Alegaon

  3. Synthesis and Antidiabetic Evaluation of Triazole-Linked Thiazolidine-2,4-dione Hybrids as α-Glucosidase and α-Amylase Inhibitors

    Article • Chemistry, June 2026, MDPI AG

    Dr Shankar G Alegaon

  4. Synthesis and evaluation of quinoline–quinazoline hybrids as potential EGFR inhibitors

    Article • Results in Chemistry, May 2026, Elsevier

    Dr Shankar G Alegaon

  5. Heterocyclic compounds with diverse biological activities: A review of quinazoline and quinazolinone derivatives

    Article • Results in Chemistry, January 2026, Elsevier

    Dr Shankar G Alegaon

  6. Modulating glucose homeostasis via expression of PPAR-γ TF: Pharmacological insights into quinolone-based hydrazones

    Article • European Journal of Medicinal Chemistry, December 2025, Elsevier

    Dr Shankar G Alegaon

  7. FOCUSED INSIGHTS INTO ALZHEIMER’S TREATMENT STRATEGIES: PHARMACOPHORE MODELLING, DFT STUDIES, MD SIMULATIONS AND SH-SY5Y NEUROPROTECTION OF NARINGIN

    Article • International Journal of Applied Pharmaceutics, November 2025, Innovare Academic Sciences Pvt Ltd

    Dr Shankar G Alegaon

  8. Sulfonamides: a versatile scaffold for diverse biological activity

    Article • Results in Chemistry, November 2025, Elsevier

    Dr Shankar G Alegaon

  9. 2-substituted 3-oxindoles as glycogen synthase kinase 3β inhibitors: insights from ML based QSAR, molecular docking, and dynamics simulations

    Article • Proceedings of the Indian National Science Academy, October 2025, Springer Science + Business Media

    Dr Shankar G Alegaon

  10. Repositioning of rhodanine-thiazole hybrids as aldose reductase inhibitors

    Article • Medicine in Drug Discovery, September 2025, Elsevier

    Dr Shankar G Alegaon

  11. Structure-guided development of Quinoline derivatives targeting kinesin spindle protein

    Article • Bioorganic & Medicinal Chemistry Letters, September 2025, Elsevier

    Dr Shankar G Alegaon

  12. Design and Cytotoxic Assessment of Novel Quinazoline Schiff Bases against A549 Cells: Unlocking Anticancer Potential

    Article • Russian Journal of Organic Chemistry, September 2025, Pleiades Publishing Ltd

    Dr Shankar G Alegaon

  13. Computational and experimental repositioning of quinoline analogues as KSP inhibitors: insights from free energy landscape and PCA analysis

    Article • Journal of Computer-Aided Molecular Design, August 2025, Springer Science + Business Media

    Dr Shankar G Alegaon

  14. Cytotoxic Potential of Newly Synthesized 4-Aminoquinoline Hybrids on MDA-MB-231 Cells: Insights from Pharmacophore Modeling and Molecular Dynamics Simulation

    Article • Russian Journal of Bioorganic Chemistry, July 2025, Pleiades Publishing Ltd

    Dr Shankar G Alegaon

  15. Synthesis and In vitro Biological Evaluation of Quinolone-Based Hydrazones as Potential Antidiabetic Agents Targeting Key Metabolic Enzymes

    Article • ACS Omega, July 2025, American Chemical Society (ACS)

    Dr Shankar G Alegaon

  16. Cytotoxic Potential of Newly Synthesized Quinoline–Bearing Dihydropyridine Hybrids on A549 Lung Cancer Cells

    Article • Russian Journal of Bioorganic Chemistry, June 2025, Pleiades Publishing Ltd

    Dr Shankar G Alegaon

  17. Design, synthesis and molecular dynamics simulations of thiazole-based hydrazones targeting MDA-MB-231 breast cancer cells

    Article • Bioorganic Chemistry, April 2025, Elsevier

    Dr Shankar G Alegaon

  18. Targeting cardiotoxicity: the potential of Annona squamosa L. in doxorubicin therapy

    Article • In Silico Pharmacology, March 2025, Springer Science + Business Media

    Dr Shankar G Alegaon

  19. Novel quinoline–imidazole derivatives as inhibitors of Mycobacterium tuberculosis : an integrated approach combining molecular dynamics and in-vitro studies

    Article • Molecular Simulation, March 2025, Taylor & Francis

    Dr Shankar G Alegaon

  20. Synthesis, molecular docking, dynamics study and preliminary cytotoxicity study of some coumarin linked imidazothiadiazoles

    Article • Journal of Molecular Structure, February 2025, Elsevier

    Dr Shankar G Alegaon

  21. Thiazolidine Based Quinazoline Hybrids: Synthesis, Docking, DFT, Molecular Dynamic Study, and In Vitro Antidiabetic Evaluation

    Article • Russian Journal of Bioorganic Chemistry, February 2025, Pleiades Publishing Ltd

    Dr Shankar G Alegaon

  22. Indoles as promising Therapeutics: A review of recent drug discovery efforts

    Article • Bioorganic Chemistry, January 2025, Elsevier

    Dr Shankar G Alegaon

  23. Novel rhodanine–thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach

    Article • RSC Medicinal Chemistry, January 2025, Royal Society of Chemistry

    Dr Shankar G Alegaon

  24. Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant rats

    Article • European Journal of Medicinal Chemistry, December 2024, Elsevier

    Dr Shankar G Alegaon

  25. Design, synthesis, characterization and antidiabetic evaluation of 3,5-substituted thiazolidinediones: Evidenced by network pharmacology, Molecular docking, dynamic simulation, in vitro and in vivo assessment

    Article • European Journal of Medicinal Chemistry Reports, December 2024, Elsevier

    Dr Shankar G Alegaon

  26. Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar rats

    Article • Bioorganic Chemistry, December 2024, Elsevier

    Dr Shankar G Alegaon

  27. Molecular hybridization, synthesis, in vitro α-glucosidase inhibition, in vivo antidiabetic activity and computational studies of isatin based compounds

    Article • Bioorganic Chemistry, December 2024, Elsevier

    Dr Shankar G Alegaon

  28. Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids

    Article • Journal of Molecular Structure, September 2024, Elsevier

    Dr Shankar G Alegaon

  29. Design, synthesis of new 2,4-thiazolidinediones: In-silico, in-vivo anti-diabetic and anti-inflammatory evaluation

    Article • European Journal of Medicinal Chemistry Reports, August 2024, Elsevier

    Dr Shankar G Alegaon

  30. Recent Studies of Nitrogen and Sulfur Containing Heterocyclic Analogues as Novel Antidiabetic Agents: A Review

    Article • Chemistry & Biodiversity, January 2024, Wiley

    Dr Shankar G Alegaon

  31. Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study

    Article • RSC Medicinal Chemistry, January 2024, Royal Society of Chemistry

    Dr Shankar G Alegaon

  32. Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids

    Article • Computational Biology and Chemistry, August 2023, Elsevier

    Dr Shankar G Alegaon

  33. Inverse Molecular Docking and Evaluation of Antitubercular Activities of Some Quinoline Based Heterocyclic Compounds

    Article • Chemistry Africa, October 2022, Springer Science + Business Media

    Dr Shankar G Alegaon

  34. Assessment of anti-oxidant activity and quantification of epigallocatechin in Acacia suma heartwood by HPTLC-DPPH fingerprinting method

    Article • Chemical Papers, June 2022, Springer Science + Business Media

    Dr Shankar G Alegaon

  35. Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents

    Article • Bioorganic Chemistry, November 2021, Elsevier

    Dr Shankar G Alegaon

  36. Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents

    Article • Journal of Biomolecular Structure and Dynamics, February 2021, Taylor & Francis

    Dr Shankar G Alegaon

  37. Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors

    Article • Future Journal of Pharmaceutical Sciences, January 2021, Springer Science + Business Media

    Dr Shankar G Alegaon

  38. Article • International Journal of Pharmaceutical Sciences and Research, March 2020, International Journal of Pharmaceutical Sciences and Research

    Dr Shankar G Alegaon

  39. Correction to: Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents

    Article • Future Journal of Pharmaceutical Sciences, February 2020, Springer Science + Business Media

    Dr Shankar G Alegaon

  40. Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents

    Article • Future Journal of Pharmaceutical Sciences, January 2020, Springer Science + Business Media

    Dr Shankar G Alegaon

  41. Article • International Journal of Pharmaceutical Sciences and Research, September 2018, International Journal of Pharmaceutical Sciences and Research

    Dr Shankar G Alegaon

  42. Synthesis of new 7-chloro-4-phenoxyquinoline analogues as potential antitubercular agents

    Article • Medicinal Chemistry Research, July 2017, Springer Science + Business Media

    Dr Shankar G Alegaon

  43. Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, April 2017, Elsevier

    Dr Shankar G Alegaon

  44. Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines

    Article • Bioorganic & Medicinal Chemistry Letters, April 2017, Elsevier

    Dr Shankar G Alegaon

  45. Synthesis and biological evaluation of 1,3,4-trisubstituted pyrazole analogues as anti-mycobacterial agents

    Article • Medicinal Chemistry Research, March 2017, Springer Science + Business Media

    Dr Shankar G Alegaon

  46. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, November 2014, Elsevier

    Dr Shankar G Alegaon, Dr Kirankumar Hullatti

  47. Synthesis, pharmacophore modeling, and cytotoxic activity of 2-thioxothiazolidin-4-one derivatives

    Article • Medicinal Chemistry Research, June 2014, Springer Science + Business Media

    Dr Shankar G Alegaon

  48. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents

    Article • Bioorganic Chemistry, June 2014, Elsevier

    Dr Shankar G Alegaon

  49. Synthesis and Antitubercular Activity of Novel 3,5-diaryl-4,5-dihydro-1H-pyrazole Derivatives

    Article • Drug Research, January 2014, Thieme Publishing Group

    Dr Shankar G Alegaon

  50. Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives

    Article • Medicinal Chemistry Research, August 2013, Springer Science + Business Media

    Dr Shankar G Alegaon

  51. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents

    Article • Bioorganic & Medicinal Chemistry Letters, March 2012, Elsevier

    Dr Shankar G Alegaon

  52. New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent

    Article • Medicinal Chemistry Research, November 2011, Springer Science + Business Media

    Dr Shankar G Alegaon

  53. Synthesis, characterization and antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety

    Article • Arabian Journal of Chemistry, October 2011, Elsevier

    Dr Shankar G Alegaon

  54. Microwave-Assisted Synthesis, Antimicrobial and Cytotoxic Activities of Some 4-Thioxo-Thiazolidine-2-One Derivatives

    Article • Letters in Drug Design & Discovery, August 2011, Bentham Science Publishers

    Dr Shankar G Alegaon

  55. New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties

    Article • Medicinal Chemistry Research, February 2011, Springer Science + Business Media

    Dr Shankar G Alegaon